Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-370016
Filing Date
2015-11-06
Accepted
2015-11-06 15:20:25
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d56378d10q.htm 10-Q 345648
2 EX-10.1 d56378dex101.htm EX-10.1 52451
3 EX-31.1 d56378dex311.htm EX-31.1 8968
4 EX-31.2 d56378dex312.htm EX-31.2 9309
5 EX-32.1 d56378dex321.htm EX-32.1 5158
  Complete submission text file 0001193125-15-370016.txt   1950387

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrtx-20150930.xml EX-101.INS 303273
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20150930.xsd EX-101.SCH 21748
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20150930_cal.xml EX-101.CAL 19149
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20150930_def.xml EX-101.DEF 146396
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20150930_lab.xml EX-101.LAB 145721
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20150930_pre.xml EX-101.PRE 156123
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 151206103
SIC: 2834 Pharmaceutical Preparations